Eculizumab treatment for renal failure in a pediatric patient with COVID-19.
J Nephrol
; 33(6): 1373-1376, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-802152
ABSTRACT
While there are increasing reports of acute kidney injury among hospitalized adults with COVID-19, there is still limited information on renal complications associated with COVID-19 in children. The cause of kidney involvement in COVID-19 is likely multifactorial, and appears to involve a complex process, including complement dysregulation and thrombotic microangiopathy. We present a pediatric case of COVID-19 and renal failure due to thombotic microangiopathy, successfully treated with eculizumab.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Renal Dialysis
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19
/
Kidney Failure, Chronic
Type of study:
Case report
/
Observational study
Limits:
Adolescent
/
Female
/
Humans
Language:
English
Journal:
J Nephrol
Journal subject:
Nephrology
Year:
2020
Document Type:
Article
Affiliation country:
S40620-020-00858-2
Similar
MEDLINE
...
LILACS
LIS